GCM
Gladius Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,710
| Closed | -$2.05M | – | 304 |
|
|
2024
Q2 | $2.05M | Buy |
3,710
+2,944
| +384% | +$1.63M | 0.25% | 11 |
|
|
2024
Q1 | $445K | Buy |
+766
| New | +$445K | 0.15% | 52 |
|
|
2023
Q4 | – | Sell |
-5,636
| Closed | -$2.85M | – | 324 |
|
|
2023
Q3 | $2.85M | Buy |
5,636
+5,270
| +1,440% | +$2.67M | 0.12% | 27 |
|
|
2023
Q2 | $191K | Buy |
366
+265
| +262% | +$138K | 0.01% | 54 |
|
|
2023
Q1 | $58.2K | Sell |
101
-549
| -84% | -$316K | ﹤0.01% | 124 |
|
|
2022
Q4 | $358K | Sell |
650
-3,999
| -86% | -$2.2M | 0.03% | 65 |
|
|
2022
Q3 | $2.36M | Buy |
+4,649
| New | +$2.36M | 0.1% | 27 |
|
|
2022
Q2 | – | Sell |
-124
| Closed | -$74K | – | 364 |
|
|
2022
Q1 | $74K | Sell |
124
-494
| -80% | -$295K | 0.01% | 195 |
|
|
2021
Q4 | $413K | Buy |
+618
| New | +$413K | 0.03% | 50 |
|
|
2021
Q3 | – | Sell |
-51
| Closed | -$26K | – | 59 |
|
|
2021
Q2 | $26K | Sell |
51
-2,819
| -98% | -$1.44M | ﹤0.01% | 29 |
|
|
2021
Q1 | $1.31M | Buy |
2,870
+885
| +45% | +$404K | 0.05% | 19 |
|
|
2020
Q4 | $925K | Buy |
1,985
+1,416
| +249% | +$660K | 0.05% | 28 |
|
|
2020
Q3 | $252K | Buy |
+569
| New | +$252K | 0.03% | 44 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 71 |
|
|
2019
Q4 | – | Sell |
-142
| Closed | -$42K | – | 80 |
|
|
2019
Q3 | $42K | Buy |
+142
| New | +$42K | ﹤0.01% | 70 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 72 |
|